BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28796164)

  • 1. Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands.
    Fischöder T; Laaf D; Dey C; Elling L
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28796164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored Multivalent Neo-Glycoproteins: Synthesis, Evaluation, and Application of a Library of Galectin-3-Binding Glycan Ligands.
    Laaf D; Bojarová P; Pelantová H; Křen V; Elling L
    Bioconjug Chem; 2017 Nov; 28(11):2832-2840. PubMed ID: 28976746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling.
    Bumba L; Laaf D; Spiwok V; Elling L; Křen V; Bojarová P
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29373511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori β1,3-N-acetylglucosaminyltransferase for versatile synthesis of type 1 and type 2 poly-LacNAcs on N-linked, O-linked and I-antigen glycans.
    Peng W; Pranskevich J; Nycholat C; Gilbert M; Wakarchuk W; Paulson JC; Razi N
    Glycobiology; 2012 Nov; 22(11):1453-64. PubMed ID: 22786570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3.
    Böcker S; Laaf D; Elling L
    Biomolecules; 2015 Jul; 5(3):1671-96. PubMed ID: 26213980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.
    Stowell SR; Arthur CM; Mehta P; Slanina KA; Blixt O; Leffler H; Smith DF; Cummings RD
    J Biol Chem; 2008 Apr; 283(15):10109-23. PubMed ID: 18216021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Affinity
    Tavares MR; Bláhová M; Sedláková L; Elling L; Pelantová H; Konefał R; Etrych T; Křen V; Bojarová P; Chytil P
    Biomacromolecules; 2020 Feb; 21(2):641-652. PubMed ID: 31904940
    [No Abstract]   [Full Text] [Related]  

  • 8. Terminal alpha-linked galactose rather than N-acetyl lactosamine is ligand for bovine heart galectin-1 in N-linked oligosaccharides of glycoproteins.
    Appukuttan PS
    J Mol Recognit; 2002; 15(4):180-7. PubMed ID: 12382235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces.
    Sauerzapfe B; Krenek K; Schmiedel J; Wakarchuk WW; Pelantová H; Kren V; Elling L
    Glycoconj J; 2009 Feb; 26(2):141-59. PubMed ID: 18758940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biosynthesis of a decasaccharide prototype of multiply branched polylactosaminoglycan backbones.
    Leppanen A; Salminen H; Zhu Y; Maaheimo H; Helin J; Costello CE; Renkonen O
    Biochemistry; 1997 Jun; 36(23):7026-36. PubMed ID: 9188700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemo-enzymatic modification of poly-N-acetyllactosamine (LacNAc) oligomers and N,N-diacetyllactosamine (LacDiNAc) based on galactose oxidase treatment.
    Kupper CE; Rosencrantz RR; Henßen B; Pelantová H; Thönes S; Drozdová A; Křen V; Elling L
    Beilstein J Org Chem; 2012; 8():712-25. PubMed ID: 23015818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins.
    Hoffmann M; Hayes MR; Pietruszka J; Elling L
    Glycoconj J; 2020 Aug; 37(4):457-470. PubMed ID: 32367478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic midchain branching of polylactosamine backbones is restricted in a site-specific manner in alpha 1,3-fucosylated chains.
    Leppänen A; Niemelä R; Renkonen O
    Biochemistry; 1997 Nov; 36(44):13729-35. PubMed ID: 9354644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotinylated N-Acetyllactosamine- and N,N-Diacetyllactosamine-Based Oligosaccharides as Novel Ligands for Human Galectin-3.
    Böcker S; Elling L
    Bioengineering (Basel); 2017 Apr; 4(2):. PubMed ID: 28952509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode.
    Renkonen O; Toppila S; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Turunen JP; Renkonen R
    Glycobiology; 1997 Jun; 7(4):453-61. PubMed ID: 9184825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans.
    Talaga ML; Fan N; Fueri AL; Brown RK; Bandyopadhyay P; Dam TK
    Biochemistry; 2016 Aug; 55(32):4541-51. PubMed ID: 27427828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation.
    Wu AM; Singh T; Wu JH; Lensch M; André S; Gabius HJ
    Glycobiology; 2006 Jun; 16(6):524-37. PubMed ID: 16540530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Structural Space of the Galectin-1-Ligand Interaction.
    Bertleff-Zieschang N; Bechold J; Grimm C; Reutlinger M; Schneider P; Schneider G; Seibel J
    Chembiochem; 2017 Aug; 18(15):1477-1481. PubMed ID: 28503789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle.
    Pasek M; Ramakrishnan B; Boeggeman E; Manzoni M; Waybright TJ; Qasba PK
    Bioconjug Chem; 2009 Mar; 20(3):608-18. PubMed ID: 19245254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition factors of Ricinus communis agglutinin 1 (RCA(1)).
    Wu AM; Wu JH; Singh T; Lai LJ; Yang Z; Herp A
    Mol Immunol; 2006 Apr; 43(10):1700-15. PubMed ID: 16288808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.